ADTRAN Holdings, Inc. Common Stock vs. DNA X, Inc. Common Stock
DNA X, Inc. Common Stock (SONM) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ADTN | SONM | |
|---|---|---|
| Market Cap | $577.70 million | $4.49 million |
| Revenue (TTM) | $1.14 billion | $-27,911,000 |
| Net Income (TTM) | $-16,811,000 | $-8,547,000 |
ADTN leads on 2 of 3 size & scale factors.
Valuation
| ADTN | SONM | |
|---|---|---|
| Price / Book | 4.46 | -3.65 |
| Price / Sales | 0.51 | -0.16 |
SONM leads on 2 of 2 valuation factors.
Profitability
| ADTN | SONM | |
|---|---|---|
| Net Margin | -1.48% | 30.62% |
| Return on Equity | -12.98% | 693.75% |
SONM leads on 2 of 2 profitability factors.
Dividend
| ADTN | SONM | |
|---|---|---|
| Dividend Yield | 5.08% | — |
ADTN and SONM split the dividend factors evenly.
Risk & Sentiment
| ADTN | SONM | |
|---|---|---|
| Short Interest | 1.01% | 0.85% |
SONM leads on 1 of 1 risk & sentiment factors.
Dig deeper: ADTN overview, ADTN financials, SONM overview, SONM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.